The APAC antibody discovery market is observing robust growth, fueled by a increasing prevalence of chronic diseases and a greater focus on personalized treatment. Notable investment in research and innovation, particularly within nations like China, Japan, and East Korea, is stimulating the adoption of advanced antibody identification platforms. F